A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
Stopped Terminated not based on safety concerns, but due to insufficient efficacy.
Conditions
Interventions
- DRUG: LY2127399
- DRUG: Placebo Q2W
- DRUG: Placebo Q4W
- DRUG: Methotrexate
Sponsor
Eli Lilly and Company